Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer
- 1 October 2014
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 473 (1-2) , 55-63
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN2010H834LS)
This publication has 40 references indexed in Scilit:
- Human Serum Albumin and p53-Activating Peptide Fusion Protein Is Able to Promote Apoptosis and Deliver Fatty Acid-Modified MoleculesPLOS ONE, 2013
- Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticleJournal of Nanobiotechnology, 2013
- Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluationNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Cryoprotection–lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micellesJournal of The Royal Society Interface, 2011
- Albumin binding ligands and albumin conjugate uptake by cancer cellsDiabetology & Metabolic Syndrome, 2011
- Triple-Negative Breast CancerThe Cancer Journal, 2010
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerJournal of Clinical Oncology, 2008
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Journal of Clinical Oncology, 2008
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences of the United States of America, 2003